Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin America

Simple item page
dc.contributor.authorFernandez-Avila, Daniel G.
dc.contributor.authorBarahona-Correa, Julian
dc.contributor.authorRomero-Alvernia, Diana
dc.contributor.authorKowalski, Sergio
dc.contributor.authorSapag, Ana
dc.contributor.authorCachafeiro-Vilar, Antonio
dc.contributor.authorMelendez, Belia
dc.contributor.authorPastelin, Carlos
dc.contributor.authorPalleiro, Daniel
dc.contributor.authorArrieta, Dina
dc.contributor.authorReyes, Gil
dc.contributor.authorPons-Estel, Guillermo J.
dc.contributor.authorThen-Baez, Jossiell
dc.contributor.authorUgarte-Gil, Manuel F.
dc.contributor.authorCardiel, Mario H.
dc.contributor.authorColman, Nelly
dc.contributor.authorChavez, Nilmo
dc.contributor.authorBurgos, Paula, I
dc.contributor.authorMontufar, Ruben
dc.contributor.authorSandino, Sayonara
dc.contributor.authorFuentes-Silva, Yurilis J.
dc.contributor.authorSoriano, Enrique R.
dc.date.accessioned2025-01-20T22:01:36Z
dc.date.available2025-01-20T22:01:36Z
dc.date.issued2022
dc.description.abstractThe objective of our study was to describe knowledge, attitudes and practices of Latin-American rheumatology patients regarding management and follow-up of their disease during COVID-19 pandemic. A cross-sectional observational study was conducted using a digital anonymous survey. Rheumatic patients >= 18 years from non-English-speaking PANLAR countries were included. Our survey included 3502 rheumatic patients living in more than 19 Latin-American countries. Median age of patients was 45.8(36-55) years and the majority (88.9%) was female. Most frequently self-reported disease was rheumatoid arthritis (48.4%). At least one anti-rheumatic treatment was suspended by 23.4% of patients. Fear of contracting SARS-Cov2 (27.7%) and economic issues (25%) were the most common reasons for drug discontinuation. Self-rated disease activity increased from 30 (7-50) to 45 (10-70) points during the pandemic. Communication with their rheumatologist during the pandemic was required by 55.6% of patients, mainly by telephone calls (50.2%) and social network messages (47.8%). An adequate knowledge about COVID-19 was observed in 43% of patients. Patients with rheumatic diseases in Latin America were negatively affected by the COVID-19 pandemic. An increase in self-rated disease activity, a reduction in medication adherence, and hurdles for medical follow-up were reported. Teleconsultation was perceived as a valid alternative to in-person visits during the pandemic.
dc.description.funderPan American League of Rheumatology Associations (PANLAR)
dc.fuente.origenWOS
dc.identifier.doi10.1007/s00296-021-05014-y
dc.identifier.eissn1437-160X
dc.identifier.issn0172-8172
dc.identifier.urihttps://doi.org/10.1007/s00296-021-05014-y
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/93858
dc.identifier.wosidWOS:000714833400001
dc.issue.numero1
dc.language.isoen
dc.pagina.final49
dc.pagina.inicio41
dc.revistaRheumatology international
dc.rightsacceso restringido
dc.subjectCOVID-19
dc.subjectRheumatology
dc.subjectTelehealth
dc.subjectAdherence
dc.subjectKnowledge
dc.subjectBehavior
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleImpact of COVID-19 pandemic on patients with rheumatic diseases in Latin America
dc.typeartículo
dc.volumen42
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas